109 related articles for article (PubMed ID: 3157826)
21. Progress in the immunointervention of type-1 diabetes mellitus.
Schernthaner G
Horm Metab Res; 1995 Dec; 27(12):547-54. PubMed ID: 8750784
[TBL] [Abstract][Full Text] [Related]
22. Does partial preservation of residual beta-cell function justify immune intervention in recent onset Type I diabetes?
Kolb H; Gale EA
Diabetologia; 2001 Oct; 44(10):1349-53. PubMed ID: 11692186
[TBL] [Abstract][Full Text] [Related]
23. [Immunotherapy for type 1 diabetes mellitus (DM1)].
van der Torren CR; Roep BO
Ned Tijdschr Geneeskd; 2012; 156(15):A4268. PubMed ID: 22495007
[TBL] [Abstract][Full Text] [Related]
24. Metabolic and immunological effects of cyclosporin in recently diagnosed type 1 diabetes mellitus.
Assan R; Feutren G; Debray-Sachs M; Quiniou-Debrie MC; Laborie C; Thomas G; Chatenoud L; Bach JF
Lancet; 1985 Jan; 1(8420):67-71. PubMed ID: 2857024
[TBL] [Abstract][Full Text] [Related]
25. Molecular biology of type 1 (insulin-dependent) diabetes mellitus.
Lernmark A
Diabetologia; 1985 Apr; 28(4):195-203. PubMed ID: 3160627
[No Abstract] [Full Text] [Related]
26. Early immunotherapy using autologous adult stem cells reversed the effect of anti-pancreatic islets in recently diagnosed type 1 diabetes mellitus: preliminary results.
Mesples A; Majeed N; Zhang Y; Hu X
Med Sci Monit; 2013 Oct; 19():852-7. PubMed ID: 24121994
[TBL] [Abstract][Full Text] [Related]
27. [Immunological disorder in diabetes mellitus].
Takeuchi K; Jodo S; Koike T
Nihon Rinsho; 1997 Oct; 55 Suppl():700-4. PubMed ID: 9392184
[No Abstract] [Full Text] [Related]
28. Plasmapheresis in the initial treatment of insulin-dependent diabetes mellitus in children.
Ludvigsson J; Heding L; Liedén G; Marner B; Lernmark A
Br Med J (Clin Res Ed); 1983 Jan; 286(6360):176-8. PubMed ID: 6401518
[TBL] [Abstract][Full Text] [Related]
29. Cell-mediated immunity and immune complexes in the pathogenesis of type 1 (insulin-dependent) diabetes.
Pozzilli P; Di Mario U; Andreani D
Acta Diabetol Lat; 1982; 19(4):295-300. PubMed ID: 6758457
[TBL] [Abstract][Full Text] [Related]
30. Editorial Comment on type 1 diabetes and antigen-specific immunotherapy.
Lernmark Å; Larsson HE
J Intern Med; 2011 Aug; 270(2):132-5. PubMed ID: 21668820
[No Abstract] [Full Text] [Related]
31. Immunotherapy in type 1 diabetes: present status.
Pozzilli P; Kolb H
Immunol Today; 1989 Oct; 10(10):321-2. PubMed ID: 2679628
[No Abstract] [Full Text] [Related]
32. Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.
Koivisto VA; Aro A; Cantell K; Haataja M; Huttunen J; Karonen SL; Mustajoki P; Pelkonen R; Seppälä P
Diabetologia; 1984 Aug; 27(2):193-7. PubMed ID: 6386581
[TBL] [Abstract][Full Text] [Related]
33. Immunospecific therapy for type I diabetes mellitus.
Culler FL; O'Connor R; Kaufmann S; Jones KL; Roth JC
N Engl J Med; 1985 Sep; 313(11):695-6. PubMed ID: 3875034
[No Abstract] [Full Text] [Related]
34. Immunoprotection in spontaneous remission of type 1 diabetes: long-term follow-up results.
Yilmaz MT; Devrim AS; Biyal F; Satman I; Arioğlu E; Dinççag N; Karsidağ K; Ozden I; Gürel N; Sipahioğlu F
Diabetes Res Clin Pract; 1993 Feb; 19(2):151-62. PubMed ID: 8472630
[TBL] [Abstract][Full Text] [Related]
35. The influence of high dose intravenous immunoglobulins on immunological and metabolic pattern in newly diagnosed type I diabetic patients.
Pantŏ F; Giordano C; Amato MP; Pugliese A; Donatelli M; D'Acquisto G; Galluzzo A
J Autoimmun; 1990 Oct; 3(5):587-92. PubMed ID: 2252526
[TBL] [Abstract][Full Text] [Related]
36. [Lymphocyte immunophenotype in children with diabetes mellitus type I during long-term insulin therapy].
Zak KP; Malynovs'ka TM; Hruzov MA
Lik Sprava; 2001; (3):44-7. PubMed ID: 11560025
[TBL] [Abstract][Full Text] [Related]
37. Remission Phase in Paediatric Type 1 Diabetes: New Understanding and Emerging Biomarkers.
Fonolleda M; Murillo M; Vázquez F; Bel J; Vives-Pi M
Horm Res Paediatr; 2017; 88(5):307-315. PubMed ID: 28772271
[TBL] [Abstract][Full Text] [Related]
38. [Current trends in the therapy of the insulin-dependent form of diabetes mellitus (a lecture)].
Kasatkina EP
Probl Endokrinol (Mosk); 1986; 32(1):42-5. PubMed ID: 3513157
[No Abstract] [Full Text] [Related]
39. Buffy coat transfusions in early type I diabetes.
Cavanaugh J; Chopek M; Binimelis J; Leiva A; Barbosa J
Diabetes; 1987 Oct; 36(10):1089-93. PubMed ID: 3308579
[TBL] [Abstract][Full Text] [Related]
40. [Effect of azathioprine on immunologic parameters in patients with newly diagnosed insulin-dependent diabetes mellitus].
Shamkhalova MSh; Abugova IA; Shishko PI; Dedov II; Kozlov LV; Aleshkin VA; Rozina MN
Probl Endokrinol (Mosk); 1993; 39(5):16-20. PubMed ID: 8108339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
